GK
GILD icon

Graney & King’s Gilead Sciences GILD Stock Holding History

Graney & King’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1K Hold
87
– – 0.01% 228
2025
Q4 		$10.6K Hold
87
– – 0.01% 235
2025
Q3 		$9.62K Buy
87
+1
+1% +$114 0.01% 233
2025
Q2 		$9.55K Buy
86
+1
+1% +$106 0.01% 221
2025
Q1 		$9.58K Hold
85
– – 0.01% 219
2024
Q4 		$7.84K Buy
+85
New +$7.65K 0.01% 221

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Graney & King's GILD Position: Q1 2026 in Review

Graney & King held its Gilead Sciences (GILD) position steady in Q1 2026 at 87 shares worth $12.1K. The position accounts for 0.01% of the portfolio, ranked #228.

Graney & King first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Graney & King held 87 shares of Gilead Sciences worth $12.1K as of Q1 2026.
  • Graney & King left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Graney & King's portfolio in Q1 2026, its #228 holding.
  • Graney & King first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.